Since 2022, the U.S. Treasury has relied heavily on issuing short duration (52 weeks or less) bills to fund the deficit.

Symbotic's contracted backlog of approximately $22.5 billion provides exceptional revenue visibility for years to come and ...

The firm is developing the immunotherapy IMNN-001 for treating ovarian cancer and assessing its efficacy in patients with homologous recombination deficiency.

We believe that Lululemon Athletica stock represents a solid value buy. Currently, it is trading at a lower than average ...

Remitly operates at scale in the digital remittance sector, serving a global customer base with a technology-driven platform.

Vitesse Energy remains a Buy, with intrinsic value estimates well above the current share price, despite oil market headwinds ...

IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has entered into a securities purchase agreement with a single ...

Winners in tech in 2026 will most likely be innovators with scale. AI leaders like Alphabet, Amazon, and Apple are embedding ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...

Buying and holding high-quality stocks is an excellent way to build wealth over the long term. Stocks represent an ownership, or equity, stake in a company. Over the long ...

AI-powered cardiac diagnostics firm HeartFlow reported a recent insider buy, as disclosed in the latest SEC filing.

The AI boom is bigger than one stock, and this lesser-known name is quietly turning NVIDIA-driven demand into real growth.